Brokerages expect that Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) will announce $6.38 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Molecular Templates’ earnings. The lowest sales estimate is $4.00 million and the highest is $8.75 million. Molecular Templates posted sales of $15.13 million during the […]
Molecular Templates (NASDAQ:MTEM – Get Rating) was downgraded by stock analysts at Bank of America from a “buy” rating to an “underperform” rating in a research note issued on Friday, The Fly reports. Several other analysts also recently commented on MTEM. Zacks Investment Research upgraded shares of Molecular Templates from a “sell” rating to a […]
Molecular Templates (NASDAQ:MTEM – Get Rating) had its price target cut by Barclays from $8.00 to $4.50 in a research note published on Wednesday morning, The Fly reports. They currently have an overweight rating on the biotechnology company’s stock. Separately, Zacks Investment Research upgraded shares of Molecular Templates from a sell rating to a hold […]
Wall Street analysts expect Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) to post $21.95 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Molecular Templates’ earnings, with the lowest sales estimate coming in at $5.00 million and the highest estimate coming in at $37.50 million. Molecular Templates […]